Critical Path Institute (C-Path) is proud to welcome four new board members who were recently elected to serve three-year terms (2012-2015). Joining the board are D. Craig Brater, MD, Dean, Indiana University School of Medicine; Samuel Broder, MD, Executive Vice President and Chief Medical Officer, Celera Genomics; James C. Greenwood, President and CEO of the Biotechnology Industry Organization (BIO); and Richard T. Myers, Jr., Regent, Arizona Board of Regents. Current board member, Peter B. Corr, PhD, General Partner, Celtic Therapeutics, LLLP, was named as the new Chairman of the Board.
